Clinical Trials Directory

Trials / Completed

CompletedNCT00472940

Prevalence of Hypogonadism in Male Cancer Patients

Status
Completed
Phase
Study type
Observational
Enrollment
135 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Accepted

Summary

Cancer and its complications are common problems. In most cases, this condition has a profound impact on survival and quality of life (QoL). Fatigue, sexual dysfunction, decreased sexual drive, depression and poor appetite are commonly seen in these patients. However, these symptoms also are seen in men with other conditions including those with low testosterone levels. The objective of this study is to determine the number of male patients with cancer that have low testosterone levels and to establish the relationship between testosterone levels and the symptoms that these patients experience.

Conditions

Timeline

Start date
2006-11-01
Primary completion
2020-09-02
Completion
2020-09-02
First posted
2007-05-14
Last updated
2020-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00472940. Inclusion in this directory is not an endorsement.

Prevalence of Hypogonadism in Male Cancer Patients (NCT00472940) · Clinical Trials Directory